TY-JOURA2-Jaffe、NormanAU-Federman、NoahAU-Chan、JasonAU-Nagy、JonOAU-Landaw, ElliotMAU-McCabe/KatelynAU-Wu/AnnaMAU-Triche-Timothi-AU-Kang-HyungGyooAU-Liu-BinAU-Marks-JamesDAU-Denny ChristopherTPY-2012DA-2012/09/11TI-Cytopolicos广度外科和辅助高剂量系统化疗并有可能产生严重的旁观者副作用,约70%局部疾病患者和只有20++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++目标化疗法显然有理改善我们对这个少年杀手的处理然而,缺乏骨科相关/专用标志阻碍了目标治疗技术开发描述小说骨科相关细胞表层抗原ACCM设计反ALCM混合脂质纳米粒子免疫 α -HPLN)专门锁定骨形细胞并提供细胞毒化化物介质doxoricin我们已经证明 α AL-HPLNs大大增强非目标HPLNs和传统亲生毒物配方的细胞毒性以这种方式 α AL-HPLNs是一个有希望的新策略 专门提供生物圈毒剂SN-1357-714XUR-https://doi.org/10.1155/2012/126906DO-10.1155/2012/126906JF-SarcomaPB-Hindawi出版公司KW-ER